Clinical Development

Good Clinical Practice(GCP)

International ethical and scientific quality standards for designing, conducting, and reporting clinical trials.

Usage Examples

All investigators completed GCP training before study initiation.
The monitor verified GCP compliance during the site visit.
The data was collected according to ICH E6(R2) requirements.

What is GCP?

Good Clinical Practice (GCP) is the international ethical and scientific quality standard for the design, conduct, performance, monitoring, auditing, recording, analysis, and reporting of clinical trials. GCP ensures that trial data is credible and that subjects' rights, safety, and well-being are protected.

ICH E6 is the foundational GCP guideline, recently updated to E6(R2) and E6(R3) to address modern trial designs and electronic systems. GCP requires informed consent, IRB/EC approval, qualified investigators, adequate resources, proper documentation, and monitoring.

GCP compliance is verified through sponsor audits and regulatory inspections. Violations can invalidate trial data and result in regulatory action against investigators or sponsors.

Regulatory Context

This term appears most often in clinical development workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside ICH E6, 21 CFR 50, 21 CFR 56.

FDAEMAPMDA

When This Matters

All investigators completed GCP training before study initiation.
The monitor verified GCP compliance during the site visit.
The data was collected according to ICH E6(R2) requirements.

Common Mistakes

Applying one-region clinical assumptions to global submission strategies.
Missing protocol-to-regulation traceability for pivotal studies.
Underestimating how regional guidance updates impact trial documentation.

Related Regulations

ICH E621 CFR 5021 CFR 5621 CFR 312

Frequently Asked Questions

Key principles include: trials should be scientifically sound, subject rights and safety are paramount, informed consent is required, IRB/EC approval is necessary, investigators must be qualified, and data must be verifiable and accurate.

Yes, ICH E6 requires that investigators and staff be qualified by education, training, and experience. Most sponsors and institutions require documented GCP training that is refreshed periodically.

ICH E6(R3) is the latest revision of GCP guidelines, incorporating principles for modern trials including decentralized trials, electronic systems, risk-based approaches, and stakeholder engagement.